Notice NOT-CA-22-018 from the NIH Guide for Grants and Contracts

Notice NOT-AI-22-011 from the NIH Guide for Grants and Contracts

1 year Fixed Term Contract: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Post Doc to join a leading pharmaceutical company based in the Slough, Berkshire area. As the Bioinformatics Post... Slough

Genomic selection (the analysis of the genome and selection of traits important to commercial. Position requires extensive interaction with both bioinformatics…
From Genus PIC - Thu, 18 Nov 2021 07:29:09 GMT - View all Waunakee, WI jobs

Genomic selection (the analysis of the genome and selection of traits important to commercial. Experience with molecular biology (DNA and RNA extraction and…
From Genus PIC - Thu, 18 Nov 2021 07:29:05 GMT - View all DeForest, WI jobs

Work independently and in teams to develop, implement, and utilize phage naïve or immune libraries for antibody discovery and optimization.
From Indeed - Wed, 17 Nov 2021 23:52:23 GMT - View all Madison, WI jobs

£37,865 - £44,900: Wellcome Sanger Institute: The Opportunity:  We are seeking a talented bioinformatician or scientist, with strong informatics skills, who is interest in developing a dynamic,... Cambridge, Cambridgeshire

Significant experience in molecular biology, including PCR, qPCR, cloning, primers/gRNA design and CRISPR design, or strong bioinformatics skills, including…
From University of Wisconsin–Madison - Wed, 17 Nov 2021 18:57:34 GMT - View all Madison, WI jobs

Notice NOT-DE-21-020 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-EY-21-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) aims to support collaborative studies of a unique resource of patient-derived induced pluripotent stem cell (iPSC) lines generated by the NEI age-related macular degeneration (AMD) Integrative Biology Initiative. This resource also includes clinical, genomic, and imaging data from the patients from which these cells were derived, and a set of isogenic control cell lines in which the risk allele(s) have been corrected. These cell lines and clinical data are from patients with AMD carrying high prevalence risk alleles selected from the Age-Related Eye Disease Study 2 (AREDS2). The goal of this FOA is to determine if these iPSC-derived cell lines can be used to discover the underlying pathophysiology of AMD. Collaborative effort is highly encouraged with investigators bringing in the needed areas of expertise for successful projects.

Funding Opportunity RFA-RM-22-006 from the NIH Guide for Grants and Contracts. The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) with the vision of alleviating suffering from childhood cancer and structural birth defects by fostering collaborative research to uncover the etiology of these diseases and supporting data sharing within the pediatric research community. Kids First has established and continues to develop a Data Resource including a large collection of curated genomic and phenotypic data from childhood cancer and structural birth defects cohorts and a central portal where these data and analysis tools are accessible to the research community. This FOA is intended to engage experts in a variety of activities that will enhance the utility of childhood cancer and/or structural birth defects genomic datasets generated by the Kids First program and/or associated phenotypic datasets and resources. These activities should strengthen future analyses of Kids First datasets by the broader researcher community with the ultimate goal of improving diagnostic capabilities and therapies for children and their families affected by these conditions.

Notice NOT-CE-22-001 from the NIH Guide for Grants and Contracts

Notice NOT-HS-22-006 from the NIH Guide for Grants and Contracts

Competitive Salary: F. Hoffmann-La Roche AG: At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about tran Switzerland (CH)

Notice NOT-HS-22-008 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-23-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) RFA supports secondary data analyses and/or data collection/enhancements to existing datasets to address the role of place (e.g., countries, U.S. Census regions, states, counties, neighborhoods, and locations across the urban-rural continuum) in health in order to uncover actionable knowledge to address disparities by geography and other factors such as race and ethnicity. Secondary data analyses appropriate to this FOA include those that: 1) clarify social, economic, behavioral, and ?institutional (e.g., federal to local government policies/programs, firm/industry practices, etc.) explanations for place-based health disparities (levels and trends) and/or 2) examine intersections between place and sociodemographic characteristics (e.g., gender, race, ethnicity, etc.) to better understand and address processes driving other ?health disparities. Analytic approaches that utilize quasi-experimental and other methods that yield causal estimates are preferred, though mixed methods projects that inform mechanistic insights and/or data enhancements are also appropriate. Multilevel analyses that enable the joint and synergistic examination of macro-, meso-, and individual-level factors are also encouraged.

Funding Opportunity PAR-22-055 from the NIH Guide for Grants and Contracts. This FOA invites applications from multidisciplinary teams to perform secondary data analysis, using existing datasets from two or more multi-site clinical research projects, to address scientific and clinical hypotheses relevant to neurological disorders and conditions within the NINDS mission. In this phased funding mechanism, applications are required to systematically and comprehensively perform cross-project data harmonization and curation, assessed using Go/No-go data-quality metrics, prior to funding of the second phase of data analyses. Consistent with the FAIR (findable, accessible, interoperable and reusable) data principles, this funding opportunity expects open-source cataloging of the processes and tools used for harmonization, curation, and analysis, as well as controlled access to the curated datasets.

Funding Opportunity RFA-HL-23-009 from the NIH Guide for Grants and Contracts. The Small Business Innovation Research (SBIR) Program is an important funding mechanism that the National Institutes of Health (NIH) uses to develop innovative solutions that address public health challenges. A major objective of the SBIR Program is to facilitate the commercialization of technologies developed by small business concerns (SBCs). Yet, the development of biomedical products is often impeded by a significant funding gap between the end of the SBIR Phase II award and the commercialization stage. This Funding Opportunity Announcement (FOA) invites SBIR grant applications from SBCs to support later later-stage research and development (referred to as Phase IIB) for promising projects that were previously funded by SBIR or STTR Phase II awards and will require eventual Federal regulatory approval/clearance. The goal of this FOA and the resulting Phase IIB awards is to assist applicants in pursuing the milestone(s) necessary to advance a product to regulatory approval and commercialization by promoting partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners.

Funding Opportunity PAR-22-066 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-027 This Funding Opportunity Announcement (FOA) solicits research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across development in rodents and non-human primates. The goal is to build a foundation for understanding how interactions within and among brain regions change over pre- and post-natal development, allowing for the emergence of cognitive, affective and social behaviors. To this end, projects supported will focus on neurodevelopmental trajectories in rodents or non-human primates and investigate questions using in vivo neural measures in awake, behaving animals. This FOA uses the R01 grant mechanism, whereas its companion funding opportunity seeks shorter, higher-risk R21 grant applications.

Funding Opportunity RFA-OH-22-001 from the NIH Guide for Grants and Contracts. The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for funding Education and Research Centers (ERCs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the principal means for meeting this mandate.